Empowering the future of biotech and pharma research through antibody-cell affinity and avidity measurements
|
Vysens develops and provides instruments for biomolecular interaction analysis, specifically for clinical cancer and autoimmune research. More than thirty years of experience and knowledge in the field of antibody-antigen interactions, fluidics and SPR, together with a unique novel technology, have been combined into the CellVysion. Vysens’ CellVysion is the only platform that directly measures functional antibody-cell avidity in real time, live and label-free. This easy-to-use instrument helps researchers to characterize antibodies, cells, and other biomolecules in real-time, aiding in the development of diagnostics and therapeutics. Find out how our technology works. |
CellVysion |
|
|
|
Co-funded by the European Union
EFRO project ESPRIT
Vysens is part of EFRO project “ESPRIT” (Electrochemical Surface Plasmon Resonance Imaging Technology). Together with partners ECSens (Enschede), InnatOss (Oss) and University of Twente (Enschede), we will enhance our SPR technology with ionic field actuation technology to increase mass transport by 3 – 6 orders of magnitude enabling faster measurements. During the project this will be demonstrated on Lyme disease.
